| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0003250> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0009450> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0020974> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0021022> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0028380> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0242348> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0600249> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C0600250> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33277154_HAS_TOPIC_C5444125>
?:authorAffiliation	[\'GSK, Siena, Italy.\', \'GSK, Siena, Italy. Electronic address: anja.k.seubert@gsk.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Finco_Oretta> <https://research.tib.eu/covid-19/entity/Pecetta_Simone> <https://research.tib.eu/covid-19/entity/Seubert_Anja>
?:doi	<https://research.tib.eu/covid-19/entity/S1044-5323%2820%2930043-910.1016/j.smim.2020.101427>
?:doi	S1044-5323(20)30043-910.1016/j.smim.2020.101427
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Seminars in immunology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33277154>
?:pmid	<https://research.tib.eu/covid-19/entity/33277154>
?:pmid	33277154
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	4.509
?:rankingScore_hIndex	109
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0003250_TREATS_C0009450>
?:title	Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33277154>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33277154>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all